Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence

Publications

Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence

11 April 2014

Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-risk group for hepatitis B virus (HBV) infection and transmission, but adherence to vaccination programmes is poor. We aimed to assess whether contingency management delivered in routine clinical practice increased the completion of HBV vaccination in individuals receiving opioid substitution therapy.

Modest financial incentives delivered in routine clinical practice significantly improve adherence to, and completion of, HBV vaccination programmes in patients receiving opioid substitution therapy. Achievement of this improvement in routine clinical practice should now prompt actual implementation. Drug treatment providers should employ contingency management to promote adherence to vaccination programmes. The effectiveness of routine use of contingency management to achieve long-term behaviour change remains unknown.

Please click here to read more.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.